Description
The Department of Veterans Affairs intends to award a sole source contract to Progenics Pharmaceuticals, Inc. for the provision of unit dose syringes of F-18 Piflufolastat (Pylarify) for positron emitting tomography (PET) imaging. The contract will be for a base period plus three option years, starting in Fiscal Year 2026. The contractor will be required to provide routine weekday deliveries, excluding holidays, during normal working hours to the Nuclear Medicine Department at the George E. Wahlen VA Medical Center in Salt Lake City, Utah. The contractor must also provide radiation safety equipment, such as syringe shields and shielded syringe box/carriers, and have an adequate supply of contract products to meet the requirements of the VA Medical Center.
Some key requirements of the contract include:
• Providing unit dose syringes of F-18 Piflufolastat (Pylarify) for PET imaging
• Providing radiation safety equipment, such as syringe shields and shielded syringe box/carriers
• Having an adequate supply of contract products to meet the requirements of the VA Medical Center
• Delivering products during normal working hours, excluding holidays
• Providing quality control and material defect consultation as needed
• Complying with all applicable federal and state regulations, including those related to the shipment of radioactive materials